Email this article Pulmonary hypertension in patients with systemic sclerosis with CREST-syndrome and without it
- Authors: Karoli NA1, Rebrov AP1, Orlova EE1
-
Affiliations:
- Саратовский государственный медицинский университет
- Issue: Vol 79, No 5 (2004)
- Pages: 15-18
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/29789
- ID: 29789
Cite item
Full Text
Abstract
Aim. To study incidence rate and characteristics of pulmonary hypertension development in patients with systemic sclerosis (SS).
Material and methods. The study included 31 SS patients (30 females, 1 male, age 33-75 years mean age 47.7+1.7 years).
Results. Pulmonary hypertension occurred more frequently in SS patients with CREST-syndrome than in SS patients free of this syndrome. SS patients with CREST-syndrome had also more severe ventricular hypertrophy than ventricular dilation.
Conclusion. Echocardiography proved to be a highly informative method for detection of pulmonary hypertension in patients with SS. The necessity of hemodynamical study in SS patients is emphasized.
Material and methods. The study included 31 SS patients (30 females, 1 male, age 33-75 years mean age 47.7+1.7 years).
Results. Pulmonary hypertension occurred more frequently in SS patients with CREST-syndrome than in SS patients free of this syndrome. SS patients with CREST-syndrome had also more severe ventricular hypertrophy than ventricular dilation.
Conclusion. Echocardiography proved to be a highly informative method for detection of pulmonary hypertension in patients with SS. The necessity of hemodynamical study in SS patients is emphasized.
About the authors
N A Karoli
Саратовский государственный медицинский университетСаратовский государственный медицинский университет
A P Rebrov
Саратовский государственный медицинский университетСаратовский государственный медицинский университет
E E Orlova
Саратовский государственный медицинский университетСаратовский государственный медицинский университет
References
- Гусева Н. Г. Системная склеродермия и псевдосклеродер мические синдромы. М.: Медицина; 1993.
- Fagan К. A., Collier D. H., Badesch D. В. Scleroderma-associ ated pulmonary hypertension who's at rick and why. Advance in pulmonary hypertension. www.Phassociation.org/medical, Advances_in_PH/.../Scleroderma-Associated_PH.as
- Rockall A. G., Rickards D., Shaw P. J. Imaging of the pulmonary manifestation of systemic disease. Postgrad. Med. J. 2001 77:621-638.
- Lee P., Langevilz P., Alderdice С. et al. Mortality in systemic sclerosis (scleroderma). Quart. J. Med. 1992; 82: 139-148.
- Steen V., Owens G., Fino G. et al. Pulmonary involvement ir systemic sclerosis (scleroderma). Arthr. and Rheum. 1985; 28 759-767.
- Minai O. A., Dweik R. A., Arroliga A. C. Manifestations of scleroderma pulmonary disease. Clin. Chest Med. 1998; 19: 713- 731.
- MacGregor A. J, Canavan R., Knight С. et al. Pulmonary hypertension in systemic sclerosis: risk factor for progression and consequences for survival. Rheumatology 2001; 40: 453-459.
- Murata I., Kihara H., Shinohara S. et al. Echocardiography evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndomes. Jpn. Cire J. 1992; 56: 983-991.
- Stupi A. M., Steen V. D., Owens G. R. et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthr. and Rheum. 1986; 29: 515-524.
- Yousem S. A. The pulmonary pathologic manifestations of the CREST syndrome. Hum. Pathol. 1990; 21: 467-474.
- Battle R. W., Davitt M. A., Cooper S. M. et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 1515-1519.
- Hoeper M. M. Pulmonary hypertension in collagen vascular disease. Eur. Respir. J. 2002; 19: 571-576.
- Yamane K., Ihn H., Asano Y. et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 2000; 39: 1269-1271.
- Шиллер Н., Осипов М. А. Клиническая эхокардиография. M.; 1993.
- Ungerer R. G., Tashkin D. P., Furst D. et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progression systemic sclerosis. Am. J. Med. 1983; 75: 65-74.
- D'Angelo W., Fries J., Masi A. et al. Pathologic observations in systemic sclerosis (scleroderma). Am. J. Med. 1969; 46: 428- 440.
- Koh E. Т., Lee P., Gladman D. D., Abu-Shakra M. Pulmonary hypertension in systemic sclerosis an analysis of 17 patients. Br. J. Rheumatol. 1996; 35: 989-993.
- Насонова В. А., Астапенко М. Г. Клиническая ревматология: Руководство для врачей. М.: Медицина; 1989. 175- 197.
Supplementary files
